Bupropion: A Clinically Proven Aid for Depression and Smoking Cessation
Bupropion
| Product dosage: 150mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.37 | $41.00 (0%) | 🛒 Add to cart |
| 60 | $1.07 | $82.00 $64.00 (22%) | 🛒 Add to cart |
| 90 | $0.97 | $123.00 $87.00 (29%) | 🛒 Add to cart |
| 120 | $0.93 | $164.00 $111.00 (32%) | 🛒 Add to cart |
| 180 | $0.87 | $246.00 $157.00 (36%) | 🛒 Add to cart |
| 270 | $0.84 | $369.00 $227.00 (38%) | 🛒 Add to cart |
| 360 | $0.82
Best per pill | $492.00 $297.00 (40%) | 🛒 Add to cart |
Similar products
Bupropion is a norepinephrine–dopamine reuptake inhibitor (NDRI) antidepressant approved for the treatment of major depressive disorder (MDD) and as an aid to smoking cessation treatment. It is distinguished by its unique pharmacological profile, offering efficacy with a favorable side effect spectrum relative to many traditional antidepressants, particularly regarding sexual dysfunction and weight gain. This agent functions by modulating key neurotransmitter systems implicated in mood regulation and reward pathways, providing a valuable option for patients requiring alternative or adjunctive therapy.
Features
- Active ingredient: Bupropion hydrochloride
- Available formulations: Immediate-release (IR), sustained-release (SR), and extended-release (XL) tablets
- Mechanism of action: Norepinephrine and dopamine reuptake inhibition; minimal serotonergic activity
- FDA-approved indications: Major depressive disorder, seasonal affective disorder (SAD), and smoking cessation
- Half-life: Approximately 21 hours (XL formulation), 12 hours (SR), and shorter for IR
- Metabolism: Hepatic, primarily via CYP2B6
Benefits
- Effective reduction of depressive symptoms with a lower incidence of sexual side effects compared to SSRIs/SNRIs
- Supports smoking cessation by reducing nicotine cravings and withdrawal symptoms
- Generally weight-neutral or associated with modest weight loss, rather than gain
- May improve energy, focus, and motivation in certain patient populations
- Does not commonly cause sedation, making it suitable for daytime use
- May be used as an augmentation strategy in treatment-resistant depression
Common use
Bupropion is primarily prescribed for the management of major depressive disorder in adults. It is also widely used as a non-nicotine pharmacotherapy to support smoking cessation, helping reduce withdrawal symptoms and cravings. Off-label uses may include attention-deficit/hyperactivity disorder (ADHD), bipolar depression (with caution due to seizure risk), and as an adjunct for weight management in certain cases. It is often selected for patients who have experienced undesirable side effects—such as sexual dysfunction or weight gain—with other antidepressant classes.
Dosage and direction
Dosing must be individualized based on formulation and indication. For depression, the initial dose for bupropion XL is typically 150 mg once daily, which may be increased to 300 mg daily after several days if tolerated. The maximum recommended dose is 450 mg per day. For smoking cessation, dosing usually begins at 150 mg once daily for 3 days, then increases to 150 mg twice daily (SR formulation), with treatment duration generally 7–12 weeks. Tablets should be swallowed whole and not crushed, chewed, or divided. Doses should be taken at the same time each day to maintain steady plasma concentrations.
Precautions
Patients should be monitored for emergence of anxiety, agitation, insomnia, and changes in behavior—especially upon initiation or dose adjustment. There is an increased risk of seizure, which is dose-related; caution is advised in patients with a history of seizure disorder, eating disorders, or those undergoing abrupt discontinuation of alcohol or sedatives. Blood pressure should be monitored due to potential increases. Use with caution in patients with hepatic or renal impairment; dose adjustment may be necessary. Not recommended during pregnancy unless potential benefit justifies potential risk.
Contraindications
Bupropion is contraindicated in patients with a seizure disorder or history of seizures. It must not be used in individuals with a current or prior diagnosis of bulimia or anorexia nervosa due to elevated seizure risk. Concomitant use with monoamine oxidase inhibitors (MAOIs) is contraindicated; a 14-day washout period is required before initiating bupropion. Hypersensitivity to bupropion or any component of the formulation is also a contraindication.
Possible side effect
Common side effects include dry mouth, nausea, headache, insomnia, and tremor. Less frequently, patients may experience anxiety, dizziness, excessive sweating, or tinnitus. Rash and pruritus have been reported. There is a dose-dependent risk of seizure. Rare but serious adverse effects include hypertension, severe skin reactions, and angle-closure glaucoma. Any new or worsening psychiatric symptoms (e.g., agitation, hostility, suicidal ideation) should be promptly evaluated.
Drug interaction
Bupropion is a substrate of CYP2B6 and may interact with inhibitors or inducers of this enzyme. Concomitant use with other dopaminergic or noradrenergic agents may increase the risk of adverse effects. It may lower the seizure threshold when used with other agents that predispose to seizures. Use with extreme caution alongside MAOIs. May interact with drugs that affect hepatic enzymes, such as ritonavir, carbamazepine, or phenobarbital. Alcohol should be avoided due to increased seizure risk.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is close to the time of the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Doubling up on doses is not recommended due to the increased risk of adverse effects, including seizure.
Overdose
Overdose may lead to seizures, hallucinations, loss of consciousness, tachycardia, and/or cardiac arrhythmias. Fatal outcomes have been reported, often involving multiple drug ingestion. Management is supportive and symptomatic; activated charcoal may be considered if ingestion was recent. Seizures should be managed with benzodiazepines; ECG monitoring is advised. There is no specific antidote.
Storage
Store at room temperature (20–25°C or 68–77°F), in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment options. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
Clinical studies and meta-analyses support the efficacy of bupropion in reducing symptoms of depression and aiding smoking cessation. Many patients report improved mood and reduced cravings with a tolerable side effect profile. However, individual responses vary, and some may experience limiting side effects such as insomnia or anxiety. Long-term user reviews often highlight its effectiveness as an alternative to SSRIs, particularly regarding sexual function and weight. Always consult a healthcare professional to determine if bupropion is appropriate for your specific situation.